Disturbing Study: Both Families of Incretin Drugs Appear to Cause Potentially Cancerous Changes in the Pancreas
Researchers just published a study in the journal Diabetes in which they autopsied the pancreases of 20 people with diabetes, 12 of whom were taking incretin drugs as well as those of 14 people without diabetes. Most had died of stroke or head injuries, leaving their pancreases in excellent condition. The researchers wanted to see if, in fact, as claimed, the incretin drugs--the drugs that raise the concentration of GLP-1 or mimic GLP-1--cause an increase in the beta cell mass. These drugs have been promoted with the promise that they do, that they regenerate the pancreas. This is one major reason doctors prescribe them ev...
Source: Diabetes Update - March 25, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
Instead of FaceBook, I'll be Posting Diabetes Tidbits in the Comment Section of Monthly Posts
I've had it with FaceBook. I can't control the ads they show people who come to my page, which are invariably for scams that prey on people with diabetes. I'm tired of channeling a steady flow of people with diabetes into the greedy hands of FaceBooks's abusive advertisers. Even worse, after I had recruited 1700+ people to my FB page, FB stopped showing most of them my updates, telling me I'd have to pay upwards of $100 each time I posted if I wanted the people who had subscribed to my page to see these updates. FaceBook's belief that they have a right to spam people who like my page with damaging ads while withholding the...
Source: Diabetes Update - March 11, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
March Diabetes News Snippet Post
Here are all the news items posted in March: Jennysaid... People taking Byetta, Victoza, Januvia, and Onglyza had less heart failure than those not on these drugs. http://www.sciencedaily.com/releases/2013/03/130310164109.htmHowever, it is likely this is because Avandia and Actos CAUSE heart failure, rather than that these other drugs prevent it. People are rarely put on both families of drugs at once. It may also be because these GLP-1 related drugs are mostly prescribed to affluent, younger people with diabetes and good health insurance, while poorer people are put on the cheap sulfonylurea drugs which are now known to ...
Source: Diabetes Update - March 11, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
Another Dangerously Misinterpreted Study: Insulin Doesn't Raise Cancer & Heart Disese Risk--High Blood Sugars Do
A huge, long-term UK study appears to show that for people with Type 2 Diabetes injecting insulin raises the risk of both cancer and heart disease.The study is:Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 DiabetesCraig J. Currie et al. The Journal of Clinical Endocrinology & Metabolism February 1, 2013 vol. 98 no. 2 668-677The study examined the records of 84,622 people with Type 2 Diabetes treated with 5 different drug combinations. It concludes: " In people with T2DM, exogenous insulin therapy was associated with an increased risk of diab...
Source: Diabetes Update - February 21, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
